Schedule 13G ownership disclosure

Viridian Therapeutics Inc

Security class unavailable · CUSIP: 92790C104

Event date: 2021-09-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,300,000
Percent of class
7.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-050795
Form type
SC 13G
Filer
Viridian Therapeutics, Inc.\DE
CIK
CIK 1590750
Filed
Sep 30, 2021
Reporting period
Sep 21, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub